Target intelligence / Profile preview

PRAME family member 30, pseudogene (PRAMEF30P)

Target
PRAMEF30P
Molecular classification
Other (pseudogene), Cancer-testis antigen family (PRAME family), Pseudogene (not a protein-coding gene)
01

Overview

PRAME family member 30, pseudogene" (PRAMEF30P) is a human gene classified as a **pseudogene** within the PRAME (preferentially expressed antigen in melanoma) gene family. Unlike protein-coding PRAME family members involved in cancer/testis antigen biology and cancer immunology, PRAMEF30P lacks protein-coding capacity and does not function as a therapeutic target or biomarker. As such, it is not considered relevant for drug discovery or clinical applications, and there are no functional, disease-related, or pharmacological data associated with this specific gene. Pseudogenes like PRAMEF30P are typically genomic DNA sequences similar to known genes but are nonfunctional; they often arise from gene duplication or retrotransposition events. While some PRAME family members are important for research and therapy in oncology, PRAMEF30P is not among them. This target is not a protein-coding gene, not a receptor, nor any established therapeutic target. There is no evidence it acts as a receptor, enzyme, transporter, or other functional class typical of drug targets. The entry’s focus on a pseudogene means it would be flagged as *not a true target* and *potentially an incorrect or irrelevant entry* for therapy-oriented studies. If you need data on a **functional PRAME family member** (e.g., "PRAME" or "PRAMEF1"), those are distinct from pseudogenes and have actual roles in cancer and immunotherapy research.

02

Mechanism of action

Not applicable

03

Biological functions

None (as a pseudogene, it does not encode a functional protein or have a direct biological function)
04

Disease associations

None established; PRAME family members are implicated in cancer and reproductive biology, but pseudogene members like PRAMEF30P have no reported functional or disease role

Beyond the preview

Go deeper on PRAME family member 30, pseudogene (PRAMEF30P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRAME family member 30, pseudogene (PRAMEF30P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call